145 related articles for article (PubMed ID: 27596957)
1. Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells.
Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
Stem Cell Res; 2016 Sep; 17(2):296-305. PubMed ID: 27596957
[TBL] [Abstract][Full Text] [Related]
2. Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T).
Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
Stem Cell Res; 2016 Sep; 17(2):205-207. PubMed ID: 27879207
[TBL] [Abstract][Full Text] [Related]
3. Ataxia telangiectasia derived iPS cells show preserved x-ray sensitivity and decreased chromosomal instability.
Fukawatase Y; Toyoda M; Okamura K; Nakamura K; Nakabayashi K; Takada S; Yamazaki-Inoue M; Masuda A; Nasu M; Hata K; Hanaoka K; Higuchi A; Takubo K; Umezawa A
Sci Rep; 2014 Jun; 4():5421. PubMed ID: 24970375
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene.
Masneri S; Ferraro RM; Lanzi G; Piovani G; Mori L; Barisani C; Moratto D; Plebani A; Badolato R; Soresina A; Giliani S
Stem Cell Res; 2019 Dec; 41():101596. PubMed ID: 31669783
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral Reprogramming of A-T Patient Fibroblasts to Induced Pluripotent Stem Cells.
Nayler S; Kozlov SV; Lavin MF; Wolvetang E
Methods Mol Biol; 2017; 1599():401-418. PubMed ID: 28477135
[TBL] [Abstract][Full Text] [Related]
6. An integration-free, virus-free rhesus macaque induced pluripotent stem cell line (riPSC89) from embryonic fibroblasts.
Sosa E; Kim R; Rojas EJ; Hosohama L; Hennebold JD; Orwig KE; Clark AT
Stem Cell Res; 2016 Sep; 17(2):444-447. PubMed ID: 27879222
[TBL] [Abstract][Full Text] [Related]
7. Modeling Glanzmann thrombasthenia using patient specific iPSCs and restoring platelet aggregation function by CD41 overexpression.
Hu L; Du L; Zhao Y; Li W; Ouyang Q; Zhou D; Lu G; Lin G
Stem Cell Res; 2017 Apr; 20():14-20. PubMed ID: 28232155
[TBL] [Abstract][Full Text] [Related]
8. Generation of human induced pluripotent stem cells in defined, feeder-free conditions.
Kyrkou A; Stellas D; Syrrou M; Klinakis A; Fotsis T; Murphy C
Stem Cell Res; 2016 Sep; 17(2):458-460. PubMed ID: 27879223
[TBL] [Abstract][Full Text] [Related]
9. Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells.
Wang H; Xi Y; Zheng Y; Wang X; Cooney AJ
Stem Cell Res; 2016 Mar; 16(2):522-30. PubMed ID: 26972055
[TBL] [Abstract][Full Text] [Related]
10. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions.
Kele M; Day K; Rönnholm H; Schuster J; Dahl N; Falk A
Stem Cell Res; 2016 Nov; 17(3):474-478. PubMed ID: 27789397
[TBL] [Abstract][Full Text] [Related]
11. SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs.
Lee P; Martin NT; Nakamura K; Azghadi S; Amiri M; Ben-David U; Perlman S; Gatti RA; Hu H; Lowry WE
Nat Commun; 2013; 4():1824. PubMed ID: 23652012
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
13. Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells.
Kinoshita T; Nagamatsu G; Kosaka T; Takubo K; Hotta A; Ellis J; Suda T
Biochem Biophys Res Commun; 2011 Apr; 407(2):321-6. PubMed ID: 21385566
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
[TBL] [Abstract][Full Text] [Related]
15. Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation.
Jiang J; Lv W; Ye X; Wang L; Zhang M; Yang H; Okuka M; Zhou C; Zhang X; Liu L; Li J
Cell Res; 2013 Jan; 23(1):92-106. PubMed ID: 23147797
[TBL] [Abstract][Full Text] [Related]
16. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
18. A patient-derived olfactory stem cell disease model for ataxia-telangiectasia.
Stewart R; Kozlov S; Matigian N; Wali G; Gatei M; Sutharsan R; Bellette B; Wraith-Kijas A; Cochrane J; Coulthard M; Perry C; Sinclair K; Mackay-Sim A; Lavin MF
Hum Mol Genet; 2013 Jun; 22(12):2495-509. PubMed ID: 23474819
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation.
Bharathan SP; Nandy K; Palani D; Janet A NB; Natarajan K; George B; Srivastava A; Velayudhan SR
Stem Cell Res; 2017 Apr; 20():54-57. PubMed ID: 28395741
[TBL] [Abstract][Full Text] [Related]
20. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
